# Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

> **NCT00820690** · — · UNKNOWN · sponsor: **Barretos Cancer Hospital** · enrollment: 80 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** doxorubicin
- **DRUG:** cyclophosphamide
- **DRUG:** paclitaxel
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT00820690
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2012-04
- **Final completion:** 2017-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820690, "Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00820690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*